<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>1416</billNumber>
    <createDate>2019-05-10T04:42:11Z</createDate>
    <updateDate>2021-06-11T21:59:14Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2019-05-09</introducedDate>
    <congress>116</congress>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <name>Reported by</name>
              <date>2019-06-28T17:22:39Z</date>
            </item>
            <item>
              <name>Markup by</name>
              <date>2019-06-27T14:00:38Z</date>
            </item>
            <item>
              <name>Referred to</name>
              <date>2019-05-09T19:47:33Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019</latestTitle>
        <congress>116</congress>
        <number>3991</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-11-21</actionDate>
          <text>Ordered to be Reported (Amended).</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Affordable Prescriptions for Patients Through Promoting Competition Act of 2019</latestTitle>
        <congress>116</congress>
        <number>4398</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-10-02</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Affordable Prescriptions for Patients Through Promoting Competition Act of 2019</latestTitle>
        <congress>116</congress>
        <number>5133</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2020-12-24</actionDate>
          <text>Placed on the Union Calendar, Calendar No. 578.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2019-06-28</actionDate>
        <committees />
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 132.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2019-06-28</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-06-28</actionDate>
        <links />
        <text>Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-06-27</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-05-09</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2019-05-09</actionDate>
        <links />
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <placedOnCalendarGeneralOrders>1</placedOnCalendarGeneralOrders>
        <reportedToSenate>2</reportedToSenate>
        <orderedReported>1</orderedReported>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>6</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001056</bioguideId>
        <fullName>Sen. Cornyn, John [R-TX]</fullName>
        <firstName>John</firstName>
        <middleName />
        <lastName>Cornyn</lastName>
        <party>R</party>
        <state>TX</state>
        <identifiers>
          <lisID>1692</lisID>
          <bioguideId>C001056</bioguideId>
          <gpoId>8295</gpoId>
        </identifiers>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001277</bioguideId>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <firstName>Richard</firstName>
        <middleName />
        <lastName>Blumenthal</lastName>
        <party>D</party>
        <state>CT</state>
        <identifiers>
          <lisID>2076</lisID>
          <bioguideId>B001277</bioguideId>
          <gpoId>8332</gpoId>
        </identifiers>
        <sponsorshipDate>2019-05-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>C001047</bioguideId>
        <fullName>Sen. Capito, Shelley Moore [R-WV]</fullName>
        <firstName>SHELLEY</firstName>
        <middleName>MOORE</middleName>
        <lastName>CAPITO</lastName>
        <party>R</party>
        <state>WV</state>
        <identifiers>
          <lisID>1676</lisID>
          <bioguideId>C001047</bioguideId>
          <gpoId>8223</gpoId>
        </identifiers>
        <sponsorshipDate>2019-05-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>M001111</bioguideId>
        <fullName>Sen. Murray, Patty [D-WA]</fullName>
        <firstName>PATTY</firstName>
        <middleName />
        <lastName>MURRAY</lastName>
        <party>D</party>
        <state>WA</state>
        <identifiers>
          <lisID>1409</lisID>
          <bioguideId>M001111</bioguideId>
          <gpoId>8237</gpoId>
        </identifiers>
        <sponsorshipDate>2019-05-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>S001217</bioguideId>
        <fullName>Sen. Scott, Rick  [R-FL]</fullName>
        <firstName>Rick</firstName>
        <middleName />
        <lastName>Scott</lastName>
        <party>R</party>
        <state>FL</state>
        <identifiers>
          <lisID>2470</lisID>
          <bioguideId>S001217</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-06-03</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>K000393</bioguideId>
        <fullName>Sen. Kennedy, John [R-LA]</fullName>
        <firstName>John</firstName>
        <middleName>Neely</middleName>
        <lastName>Kennedy</lastName>
        <party>R</party>
        <state>LA</state>
        <identifiers>
          <lisID>2303</lisID>
          <bioguideId>K000393</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-06-03</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>H001089</bioguideId>
        <fullName>Sen. Hawley, Josh  [R-MO]</fullName>
        <firstName>Josh</firstName>
        <middleName />
        <lastName>Hawley</lastName>
        <party>R</party>
        <state>MO</state>
        <identifiers>
          <lisID>2464</lisID>
          <bioguideId>H001089</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-06-04</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>RICHARD</firstName>
        <middleName>J.</middleName>
        <lastName>DURBIN</lastName>
        <party>D</party>
        <state>IL</state>
        <identifiers>
          <lisID>326</lisID>
          <bioguideId>D000563</bioguideId>
          <gpoId>8326</gpoId>
        </identifiers>
        <sponsorshipDate>2019-06-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>K000383</bioguideId>
        <fullName>Sen. King, Angus S., Jr. [I-ME]</fullName>
        <firstName>Angus</firstName>
        <middleName />
        <lastName>King</lastName>
        <party>I</party>
        <state>ME</state>
        <identifiers>
          <lisID>2185</lisID>
          <bioguideId>K000383</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-07-24</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>S001203</bioguideId>
        <fullName>Sen. Smith, Tina  [D-MN]</fullName>
        <firstName>Tina</firstName>
        <middleName />
        <lastName>Smith</lastName>
        <party>D</party>
        <state>MN</state>
        <identifiers>
          <lisID>2365</lisID>
          <bioguideId>S001203</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-09-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>P000595</bioguideId>
        <fullName>Sen. Peters, Gary C. [D-MI]</fullName>
        <firstName>Gary</firstName>
        <middleName>C.</middleName>
        <lastName>Peters</lastName>
        <party>D</party>
        <state>MI</state>
        <identifiers>
          <lisID>1929</lisID>
          <bioguideId>P000595</bioguideId>
          <gpoId>7994</gpoId>
        </identifiers>
        <sponsorshipDate>2019-09-25</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>M001197</bioguideId>
        <fullName>Sen. McSally, Martha [R-AZ]</fullName>
        <firstName>Martha</firstName>
        <middleName />
        <lastName>McSally</lastName>
        <party>R</party>
        <state>AZ</state>
        <identifiers>
          <lisID>2225</lisID>
          <bioguideId>M001197</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-11-13</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>F000463</bioguideId>
        <fullName>Sen. Fischer, Deb [R-NE]</fullName>
        <firstName>Deb</firstName>
        <middleName />
        <lastName>Fischer</lastName>
        <party>R</party>
        <state>NE</state>
        <identifiers>
          <lisID>2179</lisID>
          <bioguideId>F000463</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-11-13</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>T000461</bioguideId>
        <fullName>Sen. Toomey, Pat [R-PA]</fullName>
        <firstName>Pat</firstName>
        <middleName />
        <lastName>Toomey</lastName>
        <party>R</party>
        <state>PA</state>
        <identifiers>
          <lisID>1594</lisID>
          <bioguideId>T000461</bioguideId>
          <gpoId />
        </identifiers>
        <sponsorshipDate>2019-11-21</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2019-07-19T16:45:00Z</pubDate>
        <title>S. 1416, Affordable Prescriptions for Patients Act of 2019</title>
        <url>https://www.cbo.gov/publication/55472</url>
      </item>
    </cboCostEstimates>
    <laws />
    <notes />
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative remedies</name>
          </item>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Competition and antitrust</name>
          </item>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Federal Trade Commission (FTC)</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Inflation and prices</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
          <item>
            <name>Judicial review and appeals</name>
          </item>
          <item>
            <name>Manufacturing</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Commerce</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2019-05-09</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2020-08-11T15:26:00Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Affordable Prescriptions for Patients Act of 2019</b><br> <br> This bill prohibits patent thicketing and product hopping by drug manufacturers. In general, patent thicketing occurs when a drug manufacturer obtains new patents related to a previously-patented drug, biological product, or underlying chemical composition that extends the manufacturer&rsquo;s market exclusivity for that drug without demonstrating that the new patents serve a meaningful purpose other than limiting competition from generic drug manufacturers.<br> <br> Product hopping is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration&rsquo;s approved drug list, discontinues a drug, or markets a reformulation of an already-approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval. These practices are not considered product hopping if the manufacturer demonstrates that the drug was removed from the approved-drug list for safety reasons. Or, in the case of a drug reformulation, the manufacturer shows that the modified product provides a significant health benefit, is the option least likely to reduce competition, and is based on substantial financial considerations unrelated to limiting competition.<br> <br> The Federal Trade Commission may penalize violating manufacturers and bring claims in federal court to prohibit the conduct and provide restitution.</p>]]></text>
          <updateDate>2019-05-09T04:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
        <item>
          <versionCode>25</versionCode>
          <actionDate>2019-06-28</actionDate>
          <actionDesc>Reported to Senate</actionDesc>
          <lastSummaryUpdateDate>2021-03-17T17:44:02Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Affordable Prescriptions for Patients Act of 2019</b><br> <br> This bill prohibits product hopping by drug manufacturers. Product hopping is presumed when a drug manufacturer engages is a <i>hard switch</i> or a <i>soft switch</i>. A hard switch occurs when, after a manufacturer receives notice of an application for a generic drugs, either, (1) the manufacturer obtains removal of a drug from the Food and Drug Administration&rsquo;s approved drug list or the drug is moved to the discontinued products list, and the manufacturer markets or sells a follow-on product; or (2) a manufacturer announces the withdrawal or discontinuance of a listed drug, or the manufacturer destroys the inventory of a listed drug in a manner that impedes generic drug competitors, and the manufacturer markets or sells a follow-on product. A<i> follow-on product </i>is a changed, modified, or reformulated version of a manufacturer&rsquo;s already-approved drug or biological product that still treats the same medical condition.<br> <br> A soft switch occurs when a manufacturer receives notice of an application for a generic drugs, takes other actions that impede generic drug competitors, and the manufacturer markets or sells a follow-on product.<br> <br> A drug manufacturer may rebut a presumption of product hopping by demonstrating that its conduct was not intended to limit competition.<br> <br> This bill also limits the number of patents that may be included in infringement claims brought by approved biological product license holders against applicants for a biosimilar product license.</p>]]></text>
          <updateDate>2019-06-28T15:14:27Z</updateDate>
          <name>Reported to Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Affordable Prescriptions for Patients Act of 2019</title>
    <titles>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Affordable Prescriptions for Patients Act of 2019</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <parentTitleType>Short Title</parentTitleType>
        <title>Affordable Prescriptions for Patients Act of 2019</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>A bill to amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Affordable Prescriptions for Patients Act of 2019</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2019-06-28T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s1416rs/xml/BILLS-116s1416rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2019-05-09T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s1416is/xml/BILLS-116s1416is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2019-06-28</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 132.</text>
      <links />
    </latestAction>
    <calendarNumbers>
      <item>
        <calendar>Senate Calendar of Business</calendar>
        <number>0132</number>
      </item>
    </calendarNumbers>
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

